Literature DB >> 17259392

Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes.

Anna Michno1, Hanna Bielarczyk, Tadeusz Pawełczyk, Agnieszka Jankowska-Kulawy, Joanna Klimaszewska, Andrzej Szutowicz.   

Abstract

Increased activity of blood platelets contributes to vascular complications in patients with diabetes. The aim of this work was to investigate whether persisting hyperglycemia in diabetic patients generates excessive accumulation of ATP/ADP, which may underlie platelet hyperactivity. Platelet ATP and ADP levels, thiobarbituric acid-reactive species synthesis, and aggregation of platelets from patients with diabetes were 18-82% higher than in platelets from healthy participants. In patients with diabetes, platelet stimulation with thrombin caused about two times greater release of ATP and ADP than in the healthy group while decreasing intraplatelet nucleotide content to similar levels in both groups. This indicates that the increased content of adenylate nucleotides in the releasable pool in the platelets of diabetic patients does not affect their level in metabolic cytoplasmic/mitochondrial compartments. Significant correlations between platelet ATP levels and plasma fructosamine, as well as between platelet ATP/ADP and platelet activities, have been found in diabetic patients. In conclusion, chronic hyperglycemia-evoked elevations of ATP/ADP levels and release from blood platelets of patients with diabetes may be important factors underlying platelet hyperactivity in the course of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259392     DOI: 10.2337/db06-0390

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

Review 1.  Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?

Authors:  Diana A Gorog; Joseph M Sweeny; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04-14       Impact factor: 32.419

2.  Inhibition of pyruvate dehydrogenase complex activity by 3-bromopyruvate affects blood platelets responses in type 2 diabetes.

Authors:  Anna Michno; Katarzyna Grużewska; Hanna Bielarczyk; Marlena Zyśk; Andrzej Szutowicz
Journal:  Pharmacol Rep       Date:  2020-01-10       Impact factor: 3.024

3.  Vitamin D₃ prevents the increase in ectonucleotidase activities and ameliorates lipid profile in type 1 diabetic rats.

Authors:  Nicéia Spanholi Calgaroto; Pauline da Costa; Andréia Machado Cardoso; Luciane Belmonte Pereira; Juliano Marchi Vieira; Diéssica Dalenogare; Luana Paula Pelinson; Jucimara Baldissarelli; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2015-04-17       Impact factor: 3.396

Review 4.  Platelet function profiles in patients with diabetes mellitus.

Authors:  Fabiana Rollini; Francesco Franchi; Ana Muñiz-Lozano; Dominick J Angiolillo
Journal:  J Cardiovasc Transl Res       Date:  2013-02-13       Impact factor: 4.132

5.  Resveratrol Inhibits Metabolism and Affects Blood Platelet Function in Type 2 Diabetes.

Authors:  Anna Michno; Katarzyna Grużewska; Anna Ronowska; Sylwia Gul-Hinc; Marlena Zyśk; Agnieszka Jankowska-Kulawy
Journal:  Nutrients       Date:  2022-04-14       Impact factor: 6.706

Review 6.  Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells.

Authors:  Miguel Martin-Aragon Baudel; Ricardo Espinosa-Tanguma; Madeline Nieves-Cintron; Manuel F Navedo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-22       Impact factor: 5.555

7.  Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus.

Authors:  Jakub Gawryś; Jerzy Wiśniewski; Ewa Szahidewicz-Krupska; Damian Gajecki; Julia Leśniewska; Filip Majda; Karolina Gawryś; Paulina Fortuna; Piotr Mlynarz; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-09-29       Impact factor: 6.543

8.  Random forest approach for determining risk prediction and predictive factors of type 2 diabetes: large-scale health check-up data in Japan.

Authors:  Tadao Ooka; Hisashi Johno; Kazunori Nakamoto; Yoshioki Yoda; Hiroshi Yokomichi; Zentaro Yamagata
Journal:  BMJ Nutr Prev Health       Date:  2021-03-11

Review 9.  Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls.

Authors:  Max-Paul Winter; Marek Koziński; Jacek Kubica; Daniel Aradi; Jolanta M Siller-Matula
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-01-12       Impact factor: 1.426

10.  Increased ATP and ADO Overflow From Sympathetic Nerve Endings and Mesentery Endothelial Cells Plus Reduced Nitric Oxide Are Involved in Diabetic Neurovascular Dysfunction.

Authors:  M Verónica Donoso; M Jesús Mascayano; Inés M Poblete; J Pablo Huidobro-Toro
Journal:  Front Pharmacol       Date:  2018-05-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.